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Edmund MaserAbstract
The 16th International Meeting on the Enzymology and Molecular Biology of Carbonyl Metabolism, Castle of Ploen
(Schleswig-Holstein, Germany), July 10–15, 2012, covered all aspects of NAD(P)-dependent oxido-reductases that are
involved in the general metabolism of xenobiotic and physiological carbonyl compounds. Starting 30 years ago
with enzyme purification, structure elucidation and enzyme kinetics, the Carbonyl Society members have
meanwhile established internationally recognized enzyme nomenclature systems and now consider aspects of
enzyme genomics and enzyme evolution along with their roles in diseases. The 16th international meeting
included lectures from international speakers from all over the world.
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The International Meeting on the Enzymology and Mo-
lecular Biology of Carbonyl Metabolism was established
30 years ago by Prof. Dr. Henry Weiner, Purdue Univer-
sity, West Lafayette, IN, USA, and was later co-organized
by his wife Esther. Starting in 1982 in Bern, Switzerland,
the meeting was held every other year, alternately in USA
and elsewhere in the world. This has been the recurring
plan until today. At these meetings, talks and posters are
presented on oxido-reductases that use a carbonyl as a
substrate: alcohol dehydrogenases (ADH), aldehyde
dehydrogenases (ALDH), short-chain dehydrogenases/
reductases (SDR) and aldo-keto reductases (AKR). Pre-
viously, topics ranged from biochemical enzymology to
gene regulation and the function of the enzyme in the
cell. Important aspects of molecular toxicology were
introduced in parallel, such as the deleterious effects of
lipid-derived reactive aldehydes and their metabolic de-
toxification. Later, important aspects on enzyme geno-
mics and enzyme evolution were included and now cover
eukaryotic as well as prokaryotic organisms. This is why
this meeting brings so many interested and engagedCorrespondence: maser@toxi.uni-kiel.de
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reproduction in any medium, provided the orscientists from various disciplines together and has such
a great tradition and tremendous success.
The aim of the meeting is not only to provide timely
updates on all aspects within the field of carbonyl meta-
bolism to the senior scientists and to attract new investi-
gators, but also to educate and train younger scientists
and to provide them an opportunity to discuss with senior
scientists in a relaxed atmosphere. Excellent personal
interactions during the meeting have resulted in a number
of international collaborations that emerged among the
participants and were very important for the advancement
of science in the field of carbonyl metabolism.
Each of the previous 15 meetings was a unique expe-
rience for the participants. Moreover, the half-day social
excursions have become one of the most anticipated
events at each meeting.
The scientific papers of each meeting were published
in the form of a book under the editorship of Henry
Weiner and the help of three co-editors, who ensured a
review process that meets the criteria of international
peer-reviewed journals. Later, in 2001, 2003, 2009 and
2011, the manuscripts of every volume appeared as
a special issue of the international journal Chemico-
Biological Interactions. The articles represent a per-
manent record of what was presented during the
conferences and provide a view on the continuousis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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lizing enzyme super-families within the last 30 years.
The 16th meeting on the enzymology and molecular
biology of carbonyl metabolism
The 16th meeting was no exception. Sixteen countries
were represented, with 53% of participants coming from
Europe, 32% from North America and 15% from Asia
and Australia. This year's program was put together by
Hans-Joerg Martin and Edmund Maser. Over 70 talks
and posters provided the participants with a wide variety
of presentations dealing with enzymology, molecular
biology and metabolic aspects of carbonyl metabolizing
oxido-reductases. Much new information was presented,
including three dimensional structures of enzymes not
previously reported, new aspects of gene regulation, and
metabolism and enzyme mechanisms, as well as enzyme
genomics and evolution along with sequence alignments.
In addition, there were nomenclature updates for the
different enzyme super-families. Importantly, there was
an increased emphasis and information pertaining to the
emerging physiological/pathological roles and signifi-
cance of the carbonyl-metabolizing enzymes. Specific-
ally, several new milestone findings were associated to
human diseases, and the development of respective me-
dical treatment strategies was discussed. The level of the
science presented was top notch, a fact that was recog-
nized by a speaker from the pharmaceutical industry.
The full program can be seen on the homepage of the
meeting: http://www.carbonyl.toxi.uni-kiel.de/.
A new feature was the competition for the best poster
presentation by pre-doctoral and post-doctoral research-
ers. Members of the Poster Award Committee reviewed
the posters and selected two finalists who shared the
‘Henry and Esther Weiner Award 2012’ which was
named after the founder and his wife of the carbonyl
metabolism study group.
Details of the scientific programme
The conference was kicked off by Edmund Maser (Kiel
University Medical School, Germany) who first welcomed
all the participants and then gave a brief overview on the
30 years' history of the Carbonyl Metabolism meetings.
He also summarized several recent hot spots in carbonyl
metabolism research.
ALDH session
Vasilis Vasiliou (University of Colorado, USA) opened
the scientific section on the super-family of ALDH with
an introduction into ALDH evolution. He gave an up-
date on the enzymes' systematic nomenclature and sum-
marized recent findings on the physiological and
pathophysiological role of these enzymes in humans and
other organisms.Lilian Gonzalez-Segura (Universidad Nacional Autó-
noma de México, México) continued by discussing the
structural, phylogenetic and functional evidence for the
existence of specific potassium-binding sites in ALDHs.
Based on her results, she concluded that most of the
ALDH enzymes possess intra-subunit sites, few have
inter-subunit sites, and only the ALDH9s from Pseudo-
monas spp. have central-cavity sites.
Roger Holmes (Griffith University, Australia) focused
on the comparative genomics and proteomics of ALDH2
and ALDH1B1, which are both mitochondrial enzymes
that metabolize acetaldehyde and other biological alde-
hydes in the human body. He proposed that a dominant
negative heterodimerization of ALDH2*2 subunits with
ALDH1B1 may partially explain a lack of compensation
by ALDH1B1 in ALDH2*2 individuals and that the
ALDH1B1 gene originated in early vertebrates from a
retro-transposition of the ALDH2 gene.
Tom Hurley (Indiana University School of Medicine,
USA) gave a perspective on the discovery of selective
and non-selective inhibitors of ALDH1A1 and
ALDH3A1 to overcome resistance towards cyclophos-
phamide upon chemotherapy. He and his group have
identified new compounds which will be further deve-
loped in different cell line studies.
Sergey Krupenko (Medical University of South
Carolina, USA) reported on an unusual mode of
coenzyme binding in the carboxy-terminal domain
of ALDH1L1 which is a natural fusion of three unre-
lated genes and catalyzes the two-step conversion of
10-formyltetrahydrofolate to tetrahydrofolate and CO2
with NADP+ as cofactor. A variety of amino acid sub-
stitutions led him to conclude that Glu673 restricts the
affinity for the co-factor, whereas Cys707 acts as the
sensor of the co-factor redox state.
In her talk, Rosario Muñoz-Clares (Universidad Nacio-
nal Autónoma de México, México) focused on the struc-
tural and functional aspects of plant ALDH10 enzymes
and their role in glycine betaine (GB) production by oxi-
dation of betaine aldehyde (BAL). Biochemical and
phylogenetic analyses support the existence of two kinds
of ALDH10 isozymes: those with low-BAL affinity,
present in most plants, and those with high-BAL affinity,
only present in GB-accumulator plants.
Naim Stiti (University of Bonn, Germany) discussed
the role of ALDHs in abiotic stress and the detoxifica-
tion of reactive aldehydes derived from lipid peroxida-
tion in Arabidopsis thaliana. He found that the enzyme
activities were redox-dependent and that thiol groups of
redox-sensitive cysteines at the surface of the protein
subunits are critical to dimerization and inactivation.
Vasilis Vasiliou (University of Colorado, USA) intro-
duced a novel concept of an ALDH being involved in
gout, a common form of inflammatory arthritis that
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determinants of ALDH16A1 during evolution and pos-
tulated that ALDH16A1 may interact with several other
proteins associated with uric-acid formation, diabetes,
vesicular transport and protein degradation.
François Talfournier (CNRS-Université de Lorraine,
France) focused on key roles played by the structural dy-
namics associated with the co-factor binding in the cata-
lytic mechanism of ALDHs. Structural analyses together
with kinetic data from amino acid substitutions at cri-
tical residues led him to hypothesize that the co-factor
binding mode is in part responsible for the different ki-
netic behaviour of hydrolytic and CoA-dependent ALDHs.
Shih-Jiun Yin (National Defense Medical Center,
Taiwan) presented his work on the expression pattern, ac-
tivities and protein contents of ADHs and ALDHs in
human liver. He emphasized that functional allelic varia-
tions at the ADH1B and ALDH2 gene loci affect the deve-
lopment of alcoholism and may be involved in the
pathogenesis of alcohol-related liver diseases.
ADH session
Hans Jörnvall (Karolinska Institutet Stockholm, Sweden)
opened the scientific section on the ADH and high-
lighted the origin and evolution of the super-families
of medium-chain alcohol dehydrogenases/reductases
(MDR) and SDR. He concluded that ADHs have a com-
mon origin, with at least three separate emergences, the
SDRs, the metal-free MDRs and the Zn-dependent
MDRs, from the common ancestor.
Hector Riveros-Rosas (Universidad Nacional Autónoma,
México) continued with evolutionary insights on the
metabolic role developed by ADHs in animals. He claimed
that the presence of ADHs in vertebrates has not been a
consequence of chronic ethanol exposure and that their
participation in ethanol metabolism can be considered in-
cidental, and not adaptive.
Bryce Plapp (University of Iowa, USA) described the
biochemical basis for yeast strains that are fitter for
growth in the presence of allyl alcohol. He and his
coworkers did site-directed mutagenesis at critical sites
in ADH1 and determined steady-state kinetic constants.
They found that the fitter yeasts are ‘bradytrophs’
(slow growing) under fermentative conditions because
the ADHs have decreased catalytic efficiency and pro-
duce less of the toxic acrolein.
Jan-Olov Höög (Karolinska Institutet Stockholm,
Sweden) addressed the yet unknown function of mam-
malian ADH5, which so far could not be isolated as na-
tive protein. Computational methods including sequence
alignments, homology modelling and molecular dyna-
mics implied that the protein does not fold properly, is
not stable, is regulated on the mRNA level, or might
even be a pseudogene.Stephanie MacAllister (University of Toronto, Canada)
presented her research comparing the toxicity mecha-
nisms of acrolein and chloroacetaldehyde (CAA) which
are derived from the metabolism of the anti-cancer
drugs ifosfamide and cyclophosphamide. By using a va-
riety of model systems, they found that acrolein was sig-
nificantly more toxic than CAA, and that thiol groups,
such as N-acetylcysteine and cysteine, were the most ef-
fective protective agents against both acrolein and CAA
biomarker toxicities.
David Kopecny (Palacky University, Czech Republic) pre-
sented a structure-functional study on S-nitrosoglutathione
reductase from tomato. This enzyme is also known as
S-(hydroxymethyl)glutathione dehydrogenase, which
belongs to the ADH3 family branch of the ADH super-
family.
AKR/SDR session
Edmund Maser (Kiel University Medical School,
Germany) opened the scientific session on the AKR and
SDR superfamilies with a brief introduction into their
history. He then gave a perspective on important events
during the evolution of these two super-families and
highlighted the association of important AKR and SDR
to disease including diabetes, hypertension, the meta-
bolic syndrome, osteoporosis and cancer.
Bengt Persson (Linköping University, Sweden) gave a
talk on the nomenclature of the SDR and explained the
sub-division of this large super-family using bio-informatics
methods. In his opinion, identification of new SDR fa-
milies is slowing down, even though the number of SDR
enzymes increases continuously, indicating that the classi-
fication system works and that we will know all SDR fa-
milies in a not-too-distant future.
Natalia Kedishvili (University of Alabama, Birmingham,
USA) focused on the role of the SDR16C family of pro-
teins in retinoic acid homeostasis, including SDR16C4
(retinol dehydrogenase 10), which is indispensable for re-
tinoic acid biosynthesis during vertebrate embryogenesis,
SDR16C1, SDR16C5 and SDR16C6. She concluded that
the SDR16C family is essential in the regulation of retinoic
acid biosynthesis during embryogenesis and possibly in
adulthood.
Xavier Parés (Universitat Autònoma de Barcelona,
Spain) first reviewed the role of cytosolic MDR and
membrane-bound SDR in retinoid metabolism. Then, he
reported on the identification of cytosolic AKR1C3 and
AKR1B10 with retinaldehyde reductase activity, the lat-
ter having a possible relevance in cancer. He suggested
that retinoid analogues could be a good starting point
for searching AKR1B10-selective inhibitors.
Jaume Farrés (Universitat Autònoma de Barcelona,
Spain) continued with his data on AKR1C3 as a highly
efficient 9-cis-retinaldehyde reductase which is elevated
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chemotherapeutic-drug resistance. Farrés could show
that the proliferative action of AKR1C3 involves the re-
tinoic acid signalling pathway and that this is in part due
to the retinaldehyde reductase activity of AKR1C3.
Petra Haberzettl (University of Louisville, USA)
reported on the interesting observation that aldose re-
ductase (AKR1B1) protects against age-dependent insu-
lin resistance in type 2 diabetes, which she concluded
might be due to the fact that AKR1B1 metabolizes ex-
cess glucose via the polyol pathway.
Chi-Ching Hwang (Kaohsiung Medical University,
Taiwan) explained the catalytic role of the flexible sub-
strate binding loop in 3α-hydroxysteroid dehydrogenase/
carbonyl reductase (3α-HSD/CR) from Comamonas
testosteroni, which catalyzes the oxidation of androste-
rone to androstandione.
Adrian Lapthorn (University of Glasgow, UK) presented
his results on the structure and function of the aldo-keto
reductase AKR14A1 from Escherichia coli which shares
strong structural similarities with tetrameric voltage-gated
potassium channel β-subunit AKR6A2.
Trevor Penning (University of Pennsylvania, USA)
described his groundbreaking work to surmount castration-
resistant prostate cancer with AKR1C3 inhibitors. He
and co-workers have developed three major classes of
inhibitors based on non-steroidal anti-inflammatory drug
analogues in which compounds were identified to have
nano-molar potency for selective AKR1C3 inhibition.
Susanne Weber (Helmholtz Zentrum München,
Germany) described a novel human gene locus, AKR1B15,
which clusters with other members of the AKR1B sub-
family, AKR1B1 and AKR1B10, on chromosome 7. She
found highest levels of AKR1B15 mRNA in placenta and
testis, and intermediate levels in prostate, ovary and ske-
letal muscle.
Paul-Georg Germann (Takeda Pharmaceutical, Europe)
gave a perspective from industry on the translation from
biochemical research into medicinal drugs. He suggested
that the biomedical knowledge that is produced in basic re-
search in many research institutions, including universities,
should be exploited together with the industry to develop
new therapeutic strategies.
Tea Lanišnik Rižner (University of Ljubljana, Slovenia)
discussed the involvement of 17-ketosteroid reductases,
AKR1C3 and 17β-HSD type 1, in estrogen biosynthesis
in endometrial cancer. Based on her data, she concluded
that in endometrial cancer, estrogen is formed from
estrogen-sulphate and not from androstendione, suggest-
ing that the sulphatase pathway has more importance for
possible anti-estrogenic strategies than the aromatase
pathway.
Mark Petrash (University of Colorado, USA) intro-
duced an interesting concept where clues from Ayurvedaled to a potential diabetes therapy directed at aldose re-
ductase AKR1B1. Based on the observation that the In-
dian gooseberry (Emblica officinalis, amla) is used in
traditional Indian medicine to minimize diabetic compli-
cations, and that these effects were consistent with
AKR1B1 inhibition, he and co-workers identified AKR1B1
inhibitors in amla extracts.
Aruni Bhatnagar (University of Louisville, USA)
addressed the function of aldose reductase (AKR1B1) in
cardiac autophagy and reported on studies with wild-
type and AKR1B1-null mice. He concluded that AKR1B1
prevents the activation of autophagic responses either by
metabolizing glucose and/or removing aldehydes gene-
rated by oxidative changes that precede autophagy.
Oleg Barski (University of Louisville, USA) presented
his provocative theory that aldehyde quenchers such as
carnosine could serve as potential therapies for the pre-
vention and treatment of atherosclerosis and inflamma-
tion. He and colleagues found that carnosine rapidly
reacted with oxidized lipid-derived reactive aldehydes
and that carnosine feeding inhibits atherogenesis by fa-
cilitating aldehyde removal and inhibiting ER stress.
Conclusion and future perspectives
One of the strengths of this meeting was the laid-back,
congenial atmosphere, which fostered the interaction be-
tween delegates. This not only created an environment
where younger researchers could meet senior scientists,
but also further facilitated the exchange of ideas and the
start of collaborations. It was particularly gratifying to
see so much new, unpublished data being presented. In
summary, this year's Carbonyl Meeting continued the
high standard of excellence set by previous conferences.
Election of an executive committee and proposal to
found a society
Attendance remained strong throughout the meeting, in-
cluding the last session, which featured a lively debate on
the future of the ‘International Meeting on he Enzymology
and Molecular Biology of Carbonyl Metabolism’ (led by
Edmund Maser). Several attendees addressed their con-
cerns over budgetary and organisational issues, which fi-
nally resulted in the proposal to found a society. Seven
senior scientists were nominated for the Executive
Committee. It was agreed to find a name for the Society
(together with an acronym) and select a president
(chairperson), president-elect, treasurer and four ad-
ditional persons within 2 years, i.e. before the meeting
in 2014 which will be held in Philadelphia, USA.
Social program
The highlights of the social program were a boat excur-
sion on Lake Ploen on a Ploen cruiser followed by a
guided walk through Princes' Island and a concert
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Publication
Scientific contributions will appear as full peer-reviewed
papers in a Special Issue of the international journal
Chemico-Biological Interactions. The managing guest
editor (Bryce Plapp) and four associate guest editors
(Natasha Kedishvili, Tea Lanišnik-Rižner, Peter O'Brien
and Edmund Maser) will work in the review process,
which is planned to be completed in December 2012,
such that the Special Issue of Chemico-Biological Inter-
actions can appear in early 2013.
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